Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis

Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis

Background: Multiple randomized controlled trials (RCTs) have investigated the impact of adding checkpoint inhibitors to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC) patients. However, there is a lack of biomarkers that can help identify patients who would benefit from combinati...

Full description

Bibliographic Details
Main Authors: Arya Mariam Roy, Supritha Chintamaneni, Sabah Alaklabi, Hassan Awada, Kristopher Attwood, Shipra Gandhi
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Onco
Subjects:
breast cancer
neoadjuvant chemotherapy
immunotherapy
triple-negative breast cancer
checkpoint inhibitors
Online Access:https://www.mdpi.com/2673-7523/4/1/1

Internet

https://www.mdpi.com/2673-7523/4/1/1

Similar Items